Cancer Incidence and Mortality among Black Individuals, Suffolk County, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 629.4 | 486.4 | 468.9-504.3 | 307.6 | 545.1 | 516.3-575.1 | 321.8 | 448.7 | 426.6-471.7 | 162.4 | 137.8 | 128.2-148.0 | 81.6 | 174.1 | 156.5-193.0 | 80.8 | 116.0 | 104.7-128.2 |
Oral cavity and pharynx | 11.8 | 8.5 | 6.4-11.0 | 7.2 | 11.2 | 7.7-15.7 | 4.6 | 6.1 | 3.8-9.3 | 1.8 | 1.5 | 0.7-2.8 | 1.6 | 3.1 | 1.3-6.1 | 0.2 | 0.3 | 0.0-1.5 |
Esophagus | 4.0 | 2.9 | 1.7-4.6 | 3.0 | 5.5 | 2.9-9.3 | 1.0 | 1.1 | 0.4-2.8 | 4.6 | 3.6 | 2.2-5.5 | 3.6 | 7.3 | 4.1-11.9 | 1.0 | 1.1 | 0.4-2.8 |
Stomach | 11.2 | 9.1 | 6.8-11.9 | 6.4 | 13.0 | 8.6-18.7 | 4.8 | 6.7 | 4.2-10.0 | 4.0 | 3.4 | 2.0-5.2 | 2.6 | 5.5 | 2.8-9.5 | 1.4 | 1.9 | 0.7-3.9 |
Colorectal | 57.0 | 44.6 | 39.4-50.3 | 26.2 | 50.0 | 41.1-60.1 | 30.8 | 42.0 | 35.5-49.3 | 14.0 | 12.1 | 9.3-15.3 | 6.6 | 14.6 | 9.7-20.9 | 7.4 | 10.9 | 7.6-15.0 |
Colon excluding rectum | 39.8 | 32.2 | 27.7-37.2 | 16.6 | 33.8 | 26.4-42.5 | 23.2 | 32.1 | 26.4-38.7 | 11.8 | 10.1 | 7.6-13.1 | 5.2 | 11.4 | 7.2-17.0 | 6.6 | 9.5 | 6.5-13.5 |
Rectum & rectosigmoid | 17.2 | 12.4 | 9.8-15.4 | 9.6 | 16.2 | 11.6-22.0 | 7.6 | 9.9 | 6.9-13.6 | 2.2 | 2.0 | 1.0-3.5 | 1.4 | 3.2 | 1.2-6.7 | 0.8 | 1.3 | 0.4-3.3 |
Liver / intrahepatic bile duct | 11.2 | 8.3 | 6.2-10.9 | 8.2 | 14.0 | 9.8-19.3 | 3.0 | 4.0 | 2.2-6.7 | 6.8 | 5.2 | 3.5-7.3 | 4.0 | 7.2 | 4.2-11.5 | 2.8 | 3.8 | 2.0-6.4 |
Pancreas | 18.4 | 15.1 | 12.1-18.6 | 9.6 | 18.7 | 13.5-25.2 | 8.8 | 12.5 | 9.0-16.8 | 11.6 | 9.8 | 7.3-12.7 | 6.4 | 13.1 | 8.8-18.8 | 5.2 | 7.4 | 4.8-10.9 |
Larynx | 2.8 | 2.0 | 1.1-3.4 | 2.2 | 3.6 | 1.8-6.7 | 0.6 | 0.7 | 0.2-2.3 | 0.8 | 0.5 | 0.1-1.3 | 0.8 | 1.0 | 0.3-2.9 | 0.0 | 0.0 | 0.0-1.1 |
Lung and bronchus | 55.6 | 45.1 | 39.8-50.9 | 25.6 | 48.0 | 39.5-57.7 | 30.0 | 42.9 | 36.2-50.6 | 28.0 | 22.8 | 19.1-27.1 | 16.6 | 32.9 | 25.7-41.3 | 11.4 | 15.8 | 11.8-20.6 |
Melanoma of the skin | 1.6 | 1.3 | 0.6-2.7 | 0.6 | 1.1 | 0.2-3.3 | 1.0 | 1.5 | 0.5-3.6 | 0.8 | 0.7 | 0.2-1.8 | 0.6 | 1.2 | 0.2-3.5 | 0.2 | 0.3 | 0.0-1.7 |
Female breast | 102.8 | 141.1 | 128.9-154.2 | 14.2 | 19.6 | 15.2-24.8 | ||||||||||||
Cervix uteri | 3.8 | 5.3 | 3.1-8.3 | 1.0 | 1.4 | 0.4-3.2 | ||||||||||||
Corpus uterus and NOS | 26.4 | 35.9 | 29.9-42.8 | 6.2 | 9.4 | 6.3-13.4 | ||||||||||||
Ovary | 6.2 | 8.6 | 5.8-12.3 | 2.6 | 4.1 | 2.1-7.0 | ||||||||||||
Prostate | 127.6 | 215.9 | 198.4-234.4 | 13.4 | 32.2 | 24.5-41.2 | ||||||||||||
Testis | 2.0 | 2.8 | 1.3-5.4 | 0.0 | 0.0 | 0.0-1.4 | ||||||||||||
Urinary bladder (incl. in situ) | 17.6 | 14.7 | 11.7-18.2 | 12.6 | 25.4 | 19.1-33.0 | 5.0 | 7.3 | 4.6-10.8 | 4.0 | 3.8 | 2.3-5.9 | 2.4 | 6.4 | 3.2-11.2 | 1.6 | 2.5 | 1.1-4.9 |
Kidney and renal pelvis | 23.4 | 17.5 | 14.4-21.1 | 14.6 | 25.3 | 19.4-32.3 | 8.8 | 12.1 | 8.7-16.4 | 3.0 | 2.7 | 1.5-4.5 | 2.0 | 4.1 | 1.9-7.6 | 1.0 | 1.6 | 0.5-3.8 |
Brain and other central nervous system | 8.2 | 6.3 | 4.5-8.6 | 3.4 | 6.6 | 3.7-10.6 | 4.8 | 6.5 | 4.1-9.7 | 4.6 | 3.5 | 2.2-5.3 | 1.6 | 2.7 | 1.1-5.5 | 3.0 | 4.0 | 2.2-6.8 |
Thyroid | 19.2 | 14.4 | 11.6-17.7 | 4.0 | 6.7 | 4.0-10.4 | 15.2 | 21.1 | 16.5-26.5 | 0.8 | 0.7 | 0.2-1.8 | 0.2 | 0.2 | 0.0-1.7 | 0.6 | 0.9 | 0.2-2.7 |
Hodgkin lymphoma | 3.6 | 2.5 | 1.4-4.0 | 1.4 | 1.9 | 0.8-4.2 | 2.2 | 2.9 | 1.4-5.2 | 0.2 | 0.1 | 0.0-0.8 | 0.2 | 0.2 | 0.0-1.7 | 0.0 | 0.0 | 0.0-1.1 |
Non-Hodgkin lymphomas | 22.0 | 16.8 | 13.7-20.3 | 12.4 | 21.1 | 15.9-27.4 | 9.6 | 13.4 | 9.8-17.9 | 5.2 | 4.3 | 2.8-6.4 | 3.2 | 7.0 | 3.8-11.5 | 2.0 | 2.6 | 1.2-4.9 |
Myeloma | 17.2 | 14.1 | 11.2-17.6 | 9.0 | 15.9 | 11.3-21.6 | 8.2 | 12.2 | 8.7-16.7 | 5.6 | 5.1 | 3.3-7.4 | 2.8 | 7.4 | 3.9-12.4 | 2.8 | 4.1 | 2.2-6.9 |
Leukemias | 14.8 | 11.9 | 9.2-15.0 | 7.6 | 12.9 | 8.9-18.1 | 7.2 | 10.9 | 7.6-15.2 | 5.4 | 4.9 | 3.2-7.1 | 2.8 | 6.1 | 3.2-10.3 | 2.6 | 4.0 | 2.1-6.8 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.